These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 2209357)

  • 1. Myasthenia gravis.
    Linton DM; Philcox D
    Dis Mon; 1990 Nov; 36(11):593-637. PubMed ID: 2209357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic strategies for myasthenia gravis.
    Keys PA; Blume RP
    DICP; 1991 Oct; 25(10):1101-8. PubMed ID: 1803801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic options in autoimmune myasthenia gravis.
    García-Carrasco M; Escárcega RO; Fuentes-Alexandro S; Riebeling C; Cervera R
    Autoimmun Rev; 2007 Jun; 6(6):373-8. PubMed ID: 17537383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Juvenile myasthenia gravis].
    Papazian O; Alfonso I
    Medicina (B Aires); 2009; 69(1 Pt 1):71-83. PubMed ID: 19240004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic strategy in myasthenia gravis].
    Tranchant C
    Rev Neurol (Paris); 2009 Feb; 165(2):149-54. PubMed ID: 19233080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis.
    Dau PC; Lindstrom JM; Cassel CK; Denys EH; Shev EE; Spitler LE
    N Engl J Med; 1977 Nov; 297(21):1134-40. PubMed ID: 917042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A practical guide to the recognition and management of myasthenia gravis.
    Evoli A; Batocchi AP; Tonali P
    Drugs; 1996 Nov; 52(5):662-70. PubMed ID: 9118816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Myasthenia gravis: diagnosis and treatment].
    Suárez GA
    Rev Neurol; 1999 Jul 16-31; 29(2):162-5. PubMed ID: 10528332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myasthenia gravis: signs, symptoms, diagnosis, immunology, and current therapy.
    Scheife RT; Hills JR; Munsat TL
    Pharmacotherapy; 1981; 1(1):39-54. PubMed ID: 6927602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myasthenia gravis: options and timing of immunomodulatory treatment.
    Spring PJ; Spies JM
    BioDrugs; 2001; 15(3):173-83. PubMed ID: 11437683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular myasthenia gravis: response to long-term immunosuppressive treatment.
    Sommer N; Sigg B; Melms A; Weller M; Schepelmann K; Herzau V; Dichgans J
    J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):156-62. PubMed ID: 9048716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance immunosuppression in myasthenia gravis.
    Gotterer L; Li Y
    J Neurol Sci; 2016 Oct; 369():294-302. PubMed ID: 27653912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of autoimmune myasthenia gravis.
    Richman DP; Agius MA
    Neurology; 2003 Dec; 61(12):1652-61. PubMed ID: 14694025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric Myasthenia Gravis.
    Peragallo JH
    Semin Pediatr Neurol; 2017 May; 24(2):116-121. PubMed ID: 28941526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myasthenia gravis: clinical features, pathogenesis, evaluation, and medical management.
    Heitmiller RF
    Semin Thorac Cardiovasc Surg; 1999 Jan; 11(1):41-6. PubMed ID: 9930711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myasthenia Gravis.
    Drachman DB
    Semin Neurol; 2016 Oct; 36(5):419-424. PubMed ID: 27704496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ocular myasthenia: a diagnostic and management challenge--a review].
    Langmann A; Lindner S; Koch M; Diez J
    Klin Monbl Augenheilkd; 2004 Feb; 221(2):77-86. PubMed ID: 14986204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myasthenia gravis. Diagnostic methods and control measures for a chronic disease.
    Juhn MS
    Postgrad Med; 1993 Oct; 94(5):161-4, 167-71, 174. PubMed ID: 8415329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune myasthenia gravis.
    Lopate G; Pestronk A
    Hosp Pract (Off Ed); 1993 Jan; 28(1):109-12, 115-7, 121-2, passim. PubMed ID: 8380423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on muscle-specific tyrosine kinase antibody positive myasthenia gravis.
    Guptill JT; Sanders DB
    Curr Opin Neurol; 2010 Oct; 23(5):530-5. PubMed ID: 20613516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.